Back close

West Syndrome Epileptic Encephalopathy at Early Infancy

Publication Type : Journal Article

Thematic Areas : Medical Sciences

Publisher : International Journal of Research in Pharmaceutical Sciences

Source : International Journal of Research in Pharmaceutical Sciences, Volume 11, Issue 4, p.7492-7494 (2020)

Url :

Campus : Kochi

School : School of Medicine

Department : Paediatric Cardiology

Year : 2020

Abstract : West syndrome (WS), synonymously infantile spasm or epileptic spasm, is a rare type of epileptic encephalopathy occurring at early infancy that exists with variable life expectancy. It is the most common form of epileptic encephalopathy. WS presents with spasms marked by extensor or mixed movements with distinct electroencephalogram (EEG) pattern of hypsarrhythmia, flexor and psychomotor arrest. Children with west syndrome always depict abnormal EEG, but sometimes the abnormality is seen only during sleep. The incidence of infantile spasms is found closer to 1 in 2,000 children, that typically begins between 2-12 months of age and peaks between 4-8 months of age. It is observed in otherwise healthy infants and also among infants with abnormal cognitive development. If this spasm happens in older subjects, they are preferably called "epileptic spasms" rather than infantile spasms. The goal for treatment of infantile spasms is to have complete control of spasms. Hormonal therapy with ACTH or vigabatrin is the mainstay of treatment. In spite of the development of new antiepileptic drugs (AEDs), about 35-40% of cases are drug-resistant. Children affected with the west syndrome can be cured, but a successful therapy often depends on the timely diagnosis. This case report is one evidence highlighting the treatment strategy for the west syndrome, and this could be useful for any further study regarding this topic.

Cite this Research Publication : M. Gopi, Suresh, A., H., A., R., \R. P., R., M. M., and P., V. K., “West Syndrome Epileptic Encephalopathy at Early Infancy”, International Journal of Research in Pharmaceutical Sciences, vol. 11, no. 4, pp. 7492-7494, 2020.

Admissions Apply Now